We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries.
Main Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future.
Main Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future.
Over the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Level 5, 13 Garden St, Eveleigh,nsw 2015,australia
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- mseq.vc
- Keywords
- Deep tech, Innovation, Venture capital, Startups.
- HQ
- Eveleigh, NSW
Main Sequence Questions
Main Sequence's website is mseq.vc
Main Sequence's LinkedIn profile is https://au.linkedin.com/company/mainsequence
Main Sequence has
29 employees.
View email and phone details for 29
employees at Main Sequence.
Main Sequence's industry is
Venture Capital and Private Equity Principals
Main Sequence's top competitors are
Q-Ctrl,
Square Peg,
Oneventures,
Afterwork Ventures,
Investible,
Breaker,
Airtree,
Artesian (Alternative Investments),
Folklore Ventures,
Blackbird.
Main Sequence's categories are Venture Capital and Private Equity Principals
Main Sequence's founding year is 2016
